These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35000074)

  • 1. Adenosine signaling mediate pain transmission in the central nervous system.
    Zhou M; Wu J; Chang H; Fang Y; Zhang D; Guo Y
    Purinergic Signal; 2023 Mar; 19(1):245-254. PubMed ID: 35000074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain.
    Vincenzi F; Pasquini S; Borea PA; Varani K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine Receptors in Modulation of Central Nervous System Disorders.
    Choudhury H; Chellappan DK; Sengupta P; Pandey M; Gorain B
    Curr Pharm Des; 2019; 25(26):2808-2827. PubMed ID: 31309883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.
    Janes K; Symons-Liguori AM; Jacobson KA; Salvemini D
    Br J Pharmacol; 2016 Apr; 173(8):1253-67. PubMed ID: 26804983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine A1 but not A2a receptor agonist reduces hyperalgesia caused by a surgical incision in rats: a pertussis toxin-sensitive G protein-dependent process.
    Zahn PK; Straub H; Wenk M; Pogatzki-Zahn EM
    Anesthesiology; 2007 Nov; 107(5):797-806. PubMed ID: 18073555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine receptor targets for pain.
    Sawynok J
    Neuroscience; 2016 Dec; 338():1-18. PubMed ID: 26500181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A
    Kashfi S; Ghaedi K; Baharvand H; Nasr-Esfahani MH; Javan M
    Mol Neurobiol; 2017 Dec; 54(10):8128-8139. PubMed ID: 27889899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different analgesic effects of adenosine between postoperative and neuropathic pain.
    Yamaoka G; Horiuchi H; Morino T; Miura H; Ogata T
    J Orthop Sci; 2013 Jan; 18(1):130-6. PubMed ID: 22996813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy.
    Fernandez M; Nigro M; Travagli A; Pasquini S; Vincenzi F; Varani K; Borea PA; Merighi S; Gessi S
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic neuropathic pain: purine receptor modulation.
    Jacobson KA; Giancotti LA; Lauro F; Mufti F; Salvemini D
    Pain; 2020 Jul; 161(7):1425-1441. PubMed ID: 32187120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptations in adenosine signaling in drug dependence: therapeutic implications.
    Hack SP; Christie MJ
    Crit Rev Neurobiol; 2003; 15(3-4):235-74. PubMed ID: 15248812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells.
    Nakashima KI; Iwao K; Inoue T; Haga A; Tsutsumi T; Mochita MI; Fujimoto T; Tanihara H
    Exp Eye Res; 2018 May; 170():160-168. PubMed ID: 29486164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of synaptic transmission by adenosine in layer 2/3 of the rat visual cortex in vitro.
    Bannon NM; Zhang P; Ilin V; Chistiakova M; Volgushev M
    Neuroscience; 2014 Feb; 260():171-84. PubMed ID: 24355495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine receptor activation and nociception.
    Sawynok J
    Eur J Pharmacol; 1998 Apr; 347(1):1-11. PubMed ID: 9650842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Potential of Agonists and Antagonists of A1, A2a, A2b and A3 Adenosine Receptors.
    Jamwal S; Mittal A; Kumar P; Alhayani DM; Al-Aboudi A
    Curr Pharm Des; 2019; 25(26):2892-2905. PubMed ID: 31333104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A
    Okumura T; Nozu T; Ishioh M; Igarashi S; Kumei S; Ohhira M
    Physiol Behav; 2020 Jun; 220():112881. PubMed ID: 32199997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRR469, a potent A(1) adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in mice.
    Vincenzi F; Targa M; Romagnoli R; Merighi S; Gessi S; Baraldi PG; Borea PA; Varani K
    Neuropharmacology; 2014 Jun; 81():6-14. PubMed ID: 24486382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of peripheral adenosine receptors in glutamate-induced pain nociceptive behavior.
    Macedo-Júnior SJ; Nascimento FP; Luiz-Cerutti M; Santos ARS
    Purinergic Signal; 2021 Jun; 17(2):303-312. PubMed ID: 33860899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nociceptive transmission and modulation via P2X receptors in central pain syndrome.
    Kuan YH; Shyu BC
    Mol Brain; 2016 May; 9(1):58. PubMed ID: 27230068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic relevance of adenosine A2B and A2A receptors in the central nervous system.
    Popoli P; Pepponi R
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):664-74. PubMed ID: 22963436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.